Diagnostic performances and therapeutic impact of the Unyvero Implant and Tissue Infection multiplex PCR in periprosthetic joint infections
Abstract
Aim: We evaluated the diagnostic performances of Unyvero Implant and Tissue Infection multiplex PCR (mPCR) (Curetis) and the clinical impact of this PCR on therapeutic decisions. Materials & methods: A mPCR was performed on 33 joint fluids in addition to standard culture. A group of experts analyzed a posteriori the impact of the mPCR in the patient management. Results: The rate of concordance with culture was 74% (20/27). The sensitivity of the PCR was 59% and the specificity 90%. Clinicians would have started an appropriate treatment sooner for six patients (from 2 to 22 days earlier). Conclusion: The PCR would improve the management of 22% of the patients. For other patients, mPCR results have to be completed with the culture.
Graphical abstract
Papers of special note have been highlighted as: • of interest; •• of considerable interest
References
- 1. . Prosthetic joint infection update. Infect. Dis. Clin. North Am. 32(4), 843–859 (2018).
- 2. Economic burden of periprosthetic joint infection in the United States. J. Arthroplasty 27(8), 61–65.e1 (2012).
- 3. Bone and joint infections in hospitalized patients in France, 2008: clinical and economic outcomes. J. Hosp. Infect. 82(1), 40–48 (2012). • Description of the economical burden of bone and joint infections in France.
- 4. Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. J. Clin. Microbiol. 36(10), 2932–2939 (1998).
- 5. . Prosthetic joint infection. Clin. Microbiol. Rev. 27(2), 302–345 (2014).
- 6. Predictors of treatment failure for hip and knee prosthetic joint infections in the setting of 1- and 2-stage exchange arthroplasty: a multicenter retrospective cohort. Open Forum Infect. Dis. 6(11), ofz452 (2019).
- 7. Outcome and predictors of treatment failure in total hip/knee prosthetic joint infections due to Staphylococcus aureus. Clin. Infect. Dis. 53(4), 334–340 (2011).
- 8. European Centre for Disease Prevention and Control. Antimicrobial Resistance in the EU/EEA (EARS-Net) – Annual Epidemiological Report 2019. ECDC, Stockholm, Sweden (2020).
- 9. WHO. Antimicrobial Resistance: Global Report on Surveillance 2014. WHO, Geneva,Switzerland. https://apps.who.int/iris/handle/10665/112642 (2014)
- 10. . Diagnostic value of a PCR-based technique for prosthetic joint infection. J. Clin. Microbiol. 52(6), 2281–2282 (2014).
- 11. PCR-based diagnosis of prosthetic joint infection. J. Clin. Microbiol. 51(8), 2742–2746 (2013).
- 12. Evaluation of 16S rRNA gene PCR sensitivity and specificity for diagnosis of prosthetic joint infection: a prospective multicenter cross-sectional study. J. Clin. Microbiol. 52(10), 3583–3589 (2014).
- 13. Role of universal 16S rRNA gene PCR and sequencing in the diagnosis of prosthetic joint infection. J. Clin. Microbiol. 50(3), 583–589 (2012).
- 14. Efficacy of a novel PCR- and microarray-based method in diagnosis of a prosthetic joint infection. Acta Orthop. 85(2), 165–170 (2014).
- 15. Improving the etiological diagnosis of osteoarticular infections with the commercial multiplex real-time polymerase chain reaction SeptiFast®. Diagn. Microbiol. Infect. Dis. 97(1), 115002 (2020). • Evaluation of another multiplex PCR in bone and joint infection.
- 16. Diagnosis of prosthetic joint infections using UMD-Universal Kit and the automated multiplex-PCR Unyvero i60 ITI® cartridge system: a pilot study. Infection 43(5), 551–560 (2015). • First pilot study on Unyvero Implant and Tissue Infection (ITI) performances in prosthetic joint infections.
- 17. Evaluation of a commercial multiplex PCR (Unyvero i60®) designed for the diagnosis of bone and joint infections using prosthetic-joint sonication. Enferm. Infecc. Microbiol. Clin. 35(4), 236–242 (2017).
- 18. Assessment of the automated multiplex-PCR Unyvero i60 ITI® cartridge system to diagnose prosthetic joint infection: a multicentre study. Clin. Microbiol. Infec. 24(1), 83.e1–83.e6 (2018). •• The largest study evaluating the Unyvero ITI performances, with 440 samples included. Comparison with culture and 16S rRNA PCR.
- 19. Synovial fluid multiplex PCR is superior to culture for detection of low-virulent pathogens causing periprosthetic joint infection. Diagn. Microbiol. Infect. Dis. 90(2), 115–119 (2018). • Interesting study on the performances of the Unyvero ITI system, highlighting the difficulties in interpreting low-virulent pathogens detection.
- 20. How reliable is the next generation of multiplex-PCR for diagnosing prosthetic joint infection compared to the MSIS criteria? Still missing the ideal test. Hip Int. 30(Suppl. 1), 72–77 (2020).
- 21. Performance of automated multiplex PCR using sonication fluid for diagnosis of periprosthetic joint infection: a prospective cohort. Infection 45(6), 877–884 (2017).
- 22. Unyvero i60 Implant and Tissue Infection (ITI) multiplex PCR system in diagnosing periprosthetic joint infection. J. Microbiol. Meth. 121, 27–32 (2016).
- 23. Reliability of a multiplex PCR system for diagnosis of early and late prosthetic joint infections before and after broth enrichment. Int. J. Med. Microbiol. 307(6), 363–370 (2017).
- 24. First evaluation of the automated-multiplex-PCR Unyvero ITI G2 cartridge for rapid diagnosis of osteo-articular infections. Infect. Dis. Now 51(2), 179–186 (2021). • An interesting evaluation of the second version of the Unyvero ITI system. Evaluation of the performances on polymicrobial samples.
- 25. Multiplex PCR Unyvero i60 ITI application improves detection of low-virulent microorganisms in periprosthetic joint infections. Int.Orthop. 43(8), 1891–1898 (2019).
- 26. Unyvero ITI® system for the clinical resolution of discrepancies in periprosthetic joint infection diagnosis. Musculoskelet. Surg. 105(1), 39–42 (2021).
- 27. Periprosthetic joint infection: comparison of automated multiplex-PCR Unyvero i60 ITI cartridge system with bacterial culture and real-time PCR. Technol. Health Care 30(4), 1005–1015 (2022).
- 28. Molecular diagnosis of infective endocarditis by PCR amplification and direct sequencing of DNA from valve tissue. J. Clin. Microbiol. 41(2), 763–766 (2003).
- 29. Are there benefits in early diagnosis of prosthetic joint infection with multiplex polymerase chain reaction? J. Bone Jt Infect. 2(4), 175–183 (2017).
- 30. Diagnosis of periprosthetic joint infection using alpha-defensin test or multiplex-PCR: ideal diagnostic test still not found. Int. Orthop. 41(7), 1307–1313 (2017).
- 31. Improved pre-operative diagnostic accuracy for low-grade prosthetic joint infections using second-generation multiplex polymerase chain reaction on joint fluid aspirate. Int. Orthop. 44(9), 1629–1637 (2020).
- 32. Ruling out underlying infection in 200 presumed aseptic knee and hip revision arthroplasties using a multiplex PCR system. Eur. J. Clin. Microbiol. Infect. Dis. 40(6), 1283–1290 (2021).
- 33. . Rapid diagnostics of orthopedic implant-associated infections using Unyvero ITI Implant and Tissue Infection application is not optimal for Staphylococcus species identification. BMC Res. Notes 12(1), 725 (2019).
- 34. Focus on MRSA/SA SSTI assay failure in prosthetic joint infections: 213 consecutive patients later. J. Clin. Microbiol. 55(2), 635–637 (2017).
- 35. Evaluation of a genus- and group-specific rapid PCR assay panel on synovial fluid for diagnosis of prosthetic knee infection. J. Clin. Microbiol. 54(1), 120–126 (2016).
- 36. Preliminary evaluation of the development version of FilmArray BJI panel: a fast way for the detection of bacteria and fungi in bone and joint infections. Poster presented at: 27th ECCMID (European Congress of Clinical Microbiology and Infectious Diseases). Vienna, Austria, 22–25 Apr 2017 (Poster no. EV0257).
- 37. Costs analysis of PCR Unyvero™ i60-ITI technique for detecting microorganisms in patients with suspected chronic infection at musculoskeletal implants. Value Health 18(7), A351 (2015).